252 related articles for article (PubMed ID: 17554557)
1. Human pheochromocytomas show reduced p27Kip1 expression that is not associated with somatic gene mutations and rarely with deletions.
Pellegata NS; Quintanilla-Martinez L; Keller G; Liyanarachchi S; Höfler H; Atkinson MJ; Fend F
Virchows Arch; 2007 Jul; 451(1):37-46. PubMed ID: 17554557
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma.
Molatore S; Liyanarachchi S; Irmler M; Perren A; Mannelli M; Ercolino T; Beuschlein F; Jarzab B; Wloch J; Ziaja J; Zoubaa S; Neff F; Beckers J; Höfler H; Atkinson MJ; Pellegata NS
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18493-8. PubMed ID: 20937862
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
Guo Z; Lloyd RV
Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
[TBL] [Abstract][Full Text] [Related]
4. Familial pheochromocytomas and paragangliomas.
King KS; Pacak K
Mol Cell Endocrinol; 2014 Apr; 386(1-2):92-100. PubMed ID: 23933153
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss of chromosomes 8 and 19 in MENX-associated rat pheochromocytoma.
Shyla A; Hölzlwimmer G; Calzada-Wack J; Bink K; Tischenko O; Guilly MN; Chevillard S; Samson E; Graw J; Atkinson MJ; Pellegata NS
Int J Cancer; 2010 May; 126(10):2362-72. PubMed ID: 19876893
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.
Toledo RA; Qin Y; Srikantan S; Morales NP; Li Q; Deng Y; Kim SW; Pereira MA; Toledo SP; Su X; Aguiar RC; Dahia PL
Endocr Relat Cancer; 2013 Jun; 20(3):349-59. PubMed ID: 23533246
[TBL] [Abstract][Full Text] [Related]
7. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
Yao L; Schiavi F; Cascon A; Qin Y; Inglada-Pérez L; King EE; Toledo RA; Ercolino T; Rapizzi E; Ricketts CJ; Mori L; Giacchè M; Mendola A; Taschin E; Boaretto F; Loli P; Iacobone M; Rossi GP; Biondi B; Lima-Junior JV; Kater CE; Bex M; Vikkula M; Grossman AB; Gruber SB; Barontini M; Persu A; Castellano M; Toledo SP; Maher ER; Mannelli M; Opocher G; Robledo M; Dahia PL
JAMA; 2010 Dec; 304(23):2611-9. PubMed ID: 21156949
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.
Cassol CA; Winer D; Liu W; Guo M; Ezzat S; Asa SL
Mod Pathol; 2014 Aug; 27(8):1050-62. PubMed ID: 24390213
[TBL] [Abstract][Full Text] [Related]
9. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
[TBL] [Abstract][Full Text] [Related]
10. Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas.
Krawczyk A; Hasse-Lazar K; Pawlaczek A; Szpak-Ulczok S; Krajewska J; Paliczka-Cieślak E; Jurecka-Lubieniecka B; Roskosz J; Chmielik E; Ziaja J; Cierpka L; Peczkowska M; Preibisz A; Januszewicz A; Otto M; Jarzab B
Endokrynol Pol; 2010; 61(1):43-8. PubMed ID: 20205103
[TBL] [Abstract][Full Text] [Related]
11. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
12. A Guide to Pheochromocytomas and Paragangliomas.
Guilmette J; Sadow PM
Surg Pathol Clin; 2019 Dec; 12(4):951-965. PubMed ID: 31672301
[TBL] [Abstract][Full Text] [Related]
13. Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.
Geli J; Nord B; Frisk T; Edström Elder E; Ekström TJ; Carling T; Bäckdahl M; Larsson C
Int J Oncol; 2005 May; 26(5):1385-91. PubMed ID: 15809732
[TBL] [Abstract][Full Text] [Related]
14. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
[TBL] [Abstract][Full Text] [Related]
15. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas.
Kytölä S; Nord B; Elder EE; Carling T; Kjellman M; Cedermark B; Juhlin C; Höög A; Isola J; Larsson C
Genes Chromosomes Cancer; 2002 Jul; 34(3):325-32. PubMed ID: 12007193
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
[TBL] [Abstract][Full Text] [Related]
18. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.
Mannelli M; Castellano M; Schiavi F; Filetti S; Giacchè M; Mori L; Pignataro V; Bernini G; Giachè V; Bacca A; Biondi B; Corona G; Di Trapani G; Grossrubatscher E; Reimondo G; Arnaldi G; Giacchetti G; Veglio F; Loli P; Colao A; Ambrosio MR; Terzolo M; Letizia C; Ercolino T; Opocher G;
J Clin Endocrinol Metab; 2009 May; 94(5):1541-7. PubMed ID: 19223516
[TBL] [Abstract][Full Text] [Related]
19. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
Burnichon N; Cascón A; Schiavi F; Morales NP; Comino-Méndez I; Abermil N; Inglada-Pérez L; de Cubas AA; Amar L; Barontini M; de Quirós SB; Bertherat J; Bignon YJ; Blok MJ; Bobisse S; Borrego S; Castellano M; Chanson P; Chiara MD; Corssmit EP; Giacchè M; de Krijger RR; Ercolino T; Girerd X; Gómez-García EB; Gómez-Graña A; Guilhem I; Hes FJ; Honrado E; Korpershoek E; Lenders JW; Letón R; Mensenkamp AR; Merlo A; Mori L; Murat A; Pierre P; Plouin PF; Prodanov T; Quesada-Charneco M; Qin N; Rapizzi E; Raymond V; Reisch N; Roncador G; Ruiz-Ferrer M; Schillo F; Stegmann AP; Suarez C; Taschin E; Timmers HJ; Tops CM; Urioste M; Beuschlein F; Pacak K; Mannelli M; Dahia PL; Opocher G; Eisenhofer G; Gimenez-Roqueplo AP; Robledo M
Clin Cancer Res; 2012 May; 18(10):2828-37. PubMed ID: 22452945
[TBL] [Abstract][Full Text] [Related]
20. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
Korpershoek E; Favier J; Gaal J; Burnichon N; van Gessel B; Oudijk L; Badoual C; Gadessaud N; Venisse A; Bayley JP; van Dooren MF; de Herder WW; Tissier F; Plouin PF; van Nederveen FH; Dinjens WN; Gimenez-Roqueplo AP; de Krijger RR
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1472-6. PubMed ID: 21752896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
